David Barit

1.6k total citations
11 papers, 974 citations indexed

About

David Barit is a scholar working on Nephrology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Barit has authored 11 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Clinical Biochemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Barit's work include Chronic Kidney Disease and Diabetes (8 papers), Advanced Glycation End Products research (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). David Barit is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Advanced Glycation End Products research (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). David Barit collaborates with scholars based in Australia, United States and Netherlands. David Barit's co-authors include Mark E. Cooper, Karin Jandeleit‐Dahm, Sara Giunti, Tamehachi Namikoshi, Harald Schmidt, Melinda T. Coughlan, Vicki Thallas‐Bonke, Jay C. Jha, Josephine M. Forbes and Stephen P. Gray and has published in prestigious journals such as Diabetes, Hypertension and Journal of the American Society of Nephrology.

In The Last Decade

David Barit

10 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Barit Australia	8	404	264	245	234	228	11	974
Josefa Pete Australia	7	351 0.9×	329 1.2×	197 0.8×	186 0.8×	111 0.5×	9	891
Maiko Kakimoto Japan	8	285 0.7×	357 1.4×	183 0.7×	134 0.6×	141 0.6×	9	935
Adeline Tan Australia	12	578 1.4×	292 1.1×	306 1.2×	216 0.9×	83 0.4×	17	1.3k
Shinjiro Amano Japan	15	787 1.9×	478 1.8×	386 1.6×	190 0.8×	158 0.7×	20	1.5k
Tamami Okamoto Japan	15	782 1.9×	413 1.6×	390 1.6×	194 0.8×	140 0.6×	17	1.5k
Felicia Y. T. Yap Australia	12	369 0.9×	209 0.8×	495 2.0×	135 0.6×	92 0.4×	15	1.0k
Keiichiro Matoba Japan	18	154 0.4×	480 1.8×	337 1.4×	385 1.6×	134 0.6×	41	1.2k
Kohachiro Koga Japan	9	571 1.4×	217 0.8×	292 1.2×	174 0.7×	101 0.4×	11	943
Hiromi Fujishima Japan	12	152 0.4×	260 1.0×	389 1.6×	258 1.1×	93 0.4×	12	1.0k
Tamehachi Namikoshi Japan	18	156 0.4×	306 1.2×	132 0.5×	550 2.4×	220 1.0×	25	1.3k

Countries citing papers authored by David Barit

Since Specialization

Citations

This map shows the geographic impact of David Barit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Barit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Barit more than expected).

Fields of papers citing papers by David Barit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Barit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Barit. The network helps show where David Barit may publish in the future.

Co-authorship network of co-authors of David Barit

This figure shows the co-authorship network connecting the top 25 collaborators of David Barit. A scholar is included among the top collaborators of David Barit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Barit. David Barit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Wang, Julie, et al.. (2024). Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk. Research and Practice in Thrombosis and Haemostasis. 8(5). 102520–102520.

Lim, Hui Yin, Mark Tacey, David Barit, et al.. (2023). Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk. Thrombosis Research. 226. 127–135. 9 indexed citations

Thallas‐Bonke, Vicki, Jay C. Jha, Stephen P. Gray, et al.. (2014). Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiological Reports. 2(11). e12192–e12192. 87 indexed citations

Jha, Jay C., Stephen P. Gray, David Barit, et al.. (2014). Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy. Journal of the American Society of Nephrology. 25(6). 1237–1254. 295 indexed citations

You, Young‐Hyun, Shinichi Okada, Karin Jandeleit‐Dahm, et al.. (2013). Role of Nox2 in diabetic kidney disease. American Journal of Physiology-Renal Physiology. 304(7). F840–F848. 75 indexed citations

MacIsaac, Richard J., David Barit, & George Jerums. (2009). Blood Pressure Lowering and Outcomes in type 2 Diabetes: Implications of the Blood Pressure-Lowering Arm of the Advance Trial. Current Hypertension Reviews. 5(3). 168–180. 1 indexed citations

Barit, David & Mark E. Cooper. (2008). Diabetic patients and kidney protection: an attainable target. Journal of Hypertension. 26(Suppl 2). S3–S7. 7 indexed citations

Soro‐Paavonen, Aino, Anna M.D. Watson, Karri Paavonen, et al.. (2008). Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes. Diabetes. 57(9). 2461–2469. 339 indexed citations

Giunti, Sara, David Barit, & Mark E. Cooper. (2006). Mechanisms of Diabetic Nephropathy. Hypertension. 48(4). 519–526. 117 indexed citations

10.

Giunti, Sara, David Barit, & Mark E. Cooper. (2006). Diabetic nephropathy: from mechanisms to rational therapies.. PubMed. 97(3). 241–62. 42 indexed citations

11.

Hill, Prue, David Barit, & Nigel D. Toussaint. (2005). ARF in 2 patients with long-standing type 2 diabetes mellitus. American Journal of Kidney Diseases. 45(2). 429–434. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact